We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PAY
651
DELISTED
Verifone Systems Inc
PAY
| $3.33M | 0.01% |
+216,700
| New | +$3.78M |
|
|
FINL
652
DELISTED
Finish Line
FINL
| $3.33M | 0.01% |
+245,764
| New | +$2.83M |
|
|
HK
653
DELISTED
Halcon Resources Corporation
HK
| $3.33M | 0.01% |
682,932
-30,068
| -4% | -$203K |
|
654
Yum China
YUMC
$16.5B
| $3.32M | 0.01% |
80,100
-184,145
| -70% | -$7.92M |
|
655
Avient
AVNT
$4.17B
| $3.3M | 0.01% |
77,700
-4,300
| -5% | -$186K |
|
|
SRDX
656
DELISTED
Surmodics
SRDX
| $3.3M | 0.01% |
86,680
-11,400
| -12% | -$353K |
|
|
HF
657
DELISTED
HFF Inc.
HF
| $3.27M | 0.01% |
65,865
-126,483
| -66% | -$6.05M |
|
658
Sherwin-Williams
SHW
$88.2B
| $3.25M | 0.01% |
+24,900
| New | +$3.39M |
|
|
MODV
659
DELISTED
ModivCare
MODV
| $3.25M | 0.01% |
47,031
+6,613
| +16% | +$431K |
|
660
Strategy Inc
MSTR
$37.3B
| $3.24M | 0.01% |
250,890
-8,340
| -3% | -$112K |
|
661
UGI
UGI
$7.28B
| $3.2M | 0.01% |
72,000
+54,873
| +320% | +$2.46M |
|
662
Baxter International
BAX
$14.4B
| $3.17M | 0.01% |
+48,700
| New | +$3.29M |
|
663
Public Service Enterprise Group
PEG
$37.2B
| $3.15M | 0.01% |
+62,700
| New | +$3.08M |
|
664
GameStop
GME
$8.57B
| $3.11M | 0.01% |
+985,200
| New | +$4.02M |
|
|
CRCM
665
DELISTED
CARE.COM, INC.
CRCM
| $3.09M | 0.01% |
190,024
+2,847
| +2% | +$52.1K |
|
666
Unum
UNM
$14.4B
| $3.09M | 0.01% |
64,900
-29,700
| -31% | -$1.55M |
|
|
KYO
667
DELISTED
Kyocera Adr
KYO
| $3.08M | 0.01% |
54,251
+22,300
| +70% | +$1.37M |
|
|
MSB
668
Mesabi Trust
MSB
$306M
| $3.06M | 0.01% |
118,769
+77,966
| +191% | +$2.09M |
|
669
Carlyle Secured Lending
CGBD
$764M
| $3.03M | 0.01% |
169,123
-58,533
| -26% | -$1.05M |
|
670
OGE Energy
OGE
$9.6B
| $3.02M | 0.01% |
+92,100
| New | +$2.91M |
|
671
SunCoke Energy
SXC
$804M
| $3M | 0.01% |
278,761
+216,165
| +345% | +$2.45M |
|
672
Emergent Biosolutions
EBS
$227M
| $2.99M | 0.01% |
+56,761
| New | +$2.83M |
|
673
Celanese
CE
$4.8B
| $2.97M | 0.01% |
+29,600
| New | +$3.12M |
|
|
VRTU
674
DELISTED
Virtusa Corporation
VRTU
| $2.97M | 0.01% |
61,200
+50,400
| +467% | +$2.4M |
|
675
Genesco
GCO
$434M
| $2.96M | 0.01% |
72,977
-44,686
| -38% | -$1.66M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.